Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Revenue (2010 - 2025)

Curis' (CRIS) quarterly Revenue came in at $1.1 million in Q4 2025, down 65.98% on a YoY basis from $3.3 million in Q4 2024, and down 64.17% quarter-over-quarter from $3.2 million in Q3 2025.

Analysis

Curis (CRIS) Revenue (2010 - 2025) Analysis & Trends

Curis (CRIS) has reported Revenue for 16 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 65.98% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $4.3 million (down 62.17% YoY), and the FY2025 full-year result was $9.4 million, down 13.43% from the prior year.
  • Revenue slipped to $1.1 million in Q4 2025 per CRIS's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Revenue topped out at $3.3 million in Q4 2024 and bottomed at $1.1 million in Q4 2025.
  • Historically, Revenue has averaged $2.6 million across 5 years, with a median of $2.6 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Revenue advanced 24.07% in 2024, then slumped 65.98% in 2025.
  • Over 5 years, Revenue stood at $3.1 million in 2021, then declined by 7.91% to $2.9 million in 2022, then decreased by 6.62% to $2.7 million in 2023, then rose by 24.07% to $3.3 million in 2024, then plunged by 65.98% to $1.1 million in 2025.
  • According to Business Quant data, Revenue over the past three periods registered $1.1 million, $3.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 1.44 Mn
10 Curis 2.57 Mn -3.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.14 Mn
Sep 30, 2025 3.18 Mn
Jun 30, 2025 2.75 Mn
Mar 31, 2025 2.38 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 2.93 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 2.09 Mn
Dec 31, 2023 2.70 Mn
Sep 30, 2023 2.83 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 2.89 Mn
Sep 30, 2022 2.83 Mn
Jun 30, 2022 2.39 Mn
Mar 31, 2022 2.06 Mn
Dec 31, 2021 3.14 Mn
Sep 30, 2021 3.04 Mn
Jun 30, 2021 2.29 Mn
Mar 31, 2021 2.19 Mn